Connect with us

Announcements

Ignite’s Dan Bilzerian Being Sued for Excessive Spending by Former VP

Published

on

Ignite's Dan Bilzerian Being Sued for Excessive Spending by Former VP

Cannabis company – Ignite International Ltd’s CEO and Instagram playboy Dan Bilzerian is getting sued. A whistleblower who says Bilzerian’s company lost about $50 million in 2019 is taking the eccentric millionaire to court.

What Does Excessive Spending Involve?

The whistleblower is Ignite’s former executive vice president Curtis Heffernan, who says he got fired after talking to the company’s board about some strange purchases made by the company. These purchases included $60,000 spent on Star Wars guns, $75,000 on a paintball field, $31,000 on renovating a pool, $50,000 on a bed frame, $88,000 on a vault, and many others like these.

Heffernan claims that he has evidence that some of Ignites business expenses were on groceries, household products, renting luxury yachts, and transporting models. Heffernan says that when he presented these expenses to the board, Dan Bilzerian accused him of doing drugs and afterward fired him. Now, Heffernan wants compensation for damages.

What’s the Situation at Ignite?

Bilzerian’s Ignite is publicly traded on the Canadian Securities Exchange. As per a Forbes report says, it made $25 million only by selling stock and through debt. The company’s annual filing shows Ignite raised $19.9 million with convertible debt and 23.7 million with a short-term promissory note. The same filling reveals Ignite salaries were paid in cash and that the company spent money on travel and business trips, also on licensing fees for other companies owned by Bilzerian. This comes to contradict Ignite’s former president Jim McCormick, who said last year he expects positive cash flow for the company in 2020.

Ignite Board Says the Company May Not Obtain Adequate Financing

The Ignite board says in the filing that, as a result of the Coronavirus crisis and a wrong perception of the company’s brand, there’s no adequate assurance financing is going to be obtained for Ignite to function properly and develop in the future. Here’s what the CSE filing says precisely:

“The uncertainty of the Company’s ability to achieve profitable operations and its success in raising additional capital funding may cast significant doubt on the Company’s ability to continue as a going concern.”

Bilzerian’s company also got $1.2 million through the Paycheck Protection Program (PPP) that helps businesses recover from the losses suffered as a result of the COVID-19 pandemic. Bilzerian said Heffernan made ridiculous and frivolous claims, as he got fired for being incompetent and negligent. He added Ignite is going to respond with a lawsuit of its to his accusations.

Phyllis Milka is one of the newest contributors here at TOC and has a diverse, multi-year background with his experienced writing career. Be sure to stay on the lookout for what she is going to help create here.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.